Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.33NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.29NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.28NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CL.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BM.1.1.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBMNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.34NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CB.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BR.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CL.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EF.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BR.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.2.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CP.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.160.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BE.4.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.55NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HH.8.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FL.19NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FM.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
FK.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.7.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.8.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EU.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.14NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EJ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BM.1.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.123.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.9.2.2 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EW.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.1.37NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.1.4.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EW.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.17NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.8NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBF.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBPNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
CH.1.1.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.36NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.37NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.2.10NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BQ.1.21NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BN.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
A.2.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used